Skip to content
lifestyle.brownplanet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Dewpoint Therapeutics
Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026
July 17, 2026
Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026
April 21, 2026
Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026
April 20, 2026
Cronos Group Inc. to Speak at the 38th Annual ROTH Conference
March 16, 2026
Dewpoint Therapeutics Selects First-in-Class MYC Condensate Modulator Development Candidate
March 10, 2026
Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer
March 8, 2026